Skip to content

Understanding Your Laboratory Test: What It Is and What Your Results Mean

Published: August 9, 2026Updated: August 16, 2026

This test measures 2-methylcitrate levels in amniotic fluid to help detect certain inherited metabolic disorders in the fetus before birth.

Quick summary

{"Measures a specific chemical (2-methylcitrate) in the amniotic fluid surrounding the baby","Helps diagnose rare genetic metabolic disorders like propionic acidemia and methylmalonic acidemia during pregnancy","Requires amniocentesis procedure to collect the fluid sample","Results help doctors plan appropriate care and treatment for the baby after birth"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
34626-2
Short code
2Me-citrate Amn-sCnc
Synonyms
2Me-citrate Amn-sCnc
Category
chemistry
Sample
fluid
Container
Sterile tube
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
2-5 mL
Stability
Room temperature: 2h, Refrigerated: 24h
Hemolysis max
300
TAT
4–24 hours
Order
routine

This test helps your healthcare provider evaluate important aspects of your health by measuring specific substances in your body. Your doctor may order it during a routine checkup, to help diagnose a medical condition, or to monitor how well a treatment is working. Understanding what the test measures can help you see why it was recommended and what information it will provide about your overall health.

The 2-methylcitrate test measures the amount of a substance called 2-methylcitrate in the amniotic fluid. Amniotic fluid is the clear, slightly yellowish liquid that surrounds and protects the baby in the womb during pregnancy. This test is a specialized prenatal screening used to detect certain inherited metabolic disorders.

The way your sample is collected depends on the type of test your provider has ordered. Most often, a small amount of blood is drawn from a vein in your arm by a trained healthcare professional, or you may be asked to provide a urine sample in a sterile container. Your care team will give you specific instructions before the test, including any directions about fasting or avoiding certain medications, and you should follow them closely.

The sample is collected through a procedure called amniocentesis. During this procedure, a thin needle is inserted through the mother's abdomen into the uterus to withdraw a small amount of amniotic fluid. The fluid is then sent to a laboratory for analysis. Although amniocentesis carries a small risk of complications, it is a standard procedure performed when there is a concern for genetic or metabolic conditions.

Your results will be compared with reference ranges, which are the values typically seen in healthy people. Results that fall within these ranges are generally considered normal, while values that are higher or lower may suggest a condition that needs further evaluation. Many factors, including medications, diet, and recent illness, can influence your results, so your healthcare provider will review the findings with you, explain what they mean in your situation, and recommend any follow-up testing or treatment if needed.

Abnormally high levels of 2-methylcitrate in the amniotic fluid may indicate that the unborn baby has a metabolic disorder such as propionic acidemia or methylmalonic acidemia. These are rare genetic conditions where the body cannot properly break down certain proteins and fats. Early detection allows healthcare providers to prepare for special care the baby will need immediately after birth.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is primarily used for prenatal diagnosis of propionic acidemia and methylmalonic acidemia. These are autosomal recessive disorders that can cause serious health problems if not treated early. Detecting these conditions before birth enables the medical team to plan for immediate treatment after delivery, which may include special diets and medications to manage the condition. The test helps families and healthcare providers prepare for the specific needs of the baby.

Frequently asked questions

Why is this test recommended during pregnancy?
This test is usually recommended when there is a family history of metabolic disorders, or when other screening tests suggest a potential problem. It helps determine if the baby has a condition that requires special care from the moment of birth.
Is the test safe?
The procedure (amniocentesis) carries a small risk of miscarriage (about 1 in 300-500 procedures). Your healthcare provider will discuss the risks and benefits with you. The laboratory analysis itself is safe as it only requires a small amount of the collected fluid.
When will I get the results?
Results typically take several days to a couple of weeks, as the analysis requires specialized testing at a reference laboratory. Your doctor will inform you of the results and discuss any necessary next steps.
What happens if the results are abnormal?
If 2-methylcitrate levels are elevated, your healthcare provider will likely recommend additional testing to confirm the diagnosis. A genetic counselor or metabolic specialist will help you understand the condition and discuss treatment options and care planning for your baby.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy